The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.876
Bid: 0.874
Ask: 0.88
Change: 0.00 (0.00%)
Spread: 0.006 (0.686%)
Open: 0.88
High: 0.88
Low: 0.876
Prev. Close: 0.876
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

10 Jan 2024 18:15

RNS Number : 3088Z
BioPharma Credit PLC
10 January 2024
 

BioPharma Credit plc

(the "Company")

TRANSACTION IN OWN SHARES

 

BioPharma Credit PLC (the "Company") announces that today it has purchased the following number of its ordinary shares of US$0.01 each on the London Stock Exchange through J.P. Morgan Securities plc into treasury.

 

Ordinary Shares: BPCR LN

Date of purchase: 10 January 2024

Number of ordinary shares purchased: 2,480,267

Lowest price per share: $0.9340

Highest price per share: $0.9380

Trading venue: London Stock Exchange

 

Aggregate volume per date per trading venue: 2,480,267

Weighted average price per day per trading venue: $0.9369

 

Following the above transaction, the Company holds 76,750,499 of its ordinary shares in treasury and has 1,297,181,568 ordinary shares in issue (excluding treasury shares). Therefore, the total number of voting rights in the Company is 1,297,181,568. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0) 333 300 1950

 

Buchanan

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com

 

Notes to Editors:

 

BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. BioPharma Credit PLC seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. BioPharma Credit PLC seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

 

 

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDBLFFZFLXBBB
Date   Source Headline
16th Sep 20207:05 amRNSAppointment of New Director
16th Sep 20207:00 amRNSHalf-year Report
9th Sep 20204:00 pmRNSLEXICON PHARMACEUTICALS PREPAYMENT
21st Aug 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Aug 20203:25 pmRNSNotice of Half Year Results
12th Aug 20203:30 pmRNSDividend Declaration
7th Aug 20207:00 amRNSUPDATES TO THE PORTFOLIO
4th Aug 20204:30 pmRNSHolding(s) in Company
4th Aug 202011:15 amRNSHolding(s) in Company
3rd Aug 20201:15 pmRNSTotal Voting Rights
30th Jul 20204:00 pmRNSSTATEMENT REGARDING LEXICON PHARMACEUTICALS
24th Jul 20203:15 pmRNSHolding(s) in Company
21st Jul 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Jul 20207:00 amRNSAMICUS PREPAYMENT
16th Jul 20207:00 amRNSCOMPLETION OF SHARE BUYBACK PROGRAMME
15th Jul 20205:30 pmRNSTransaction in Own Shares
14th Jul 20205:30 pmRNSTransaction in Own Shares
13th Jul 20205:45 pmRNSTransaction in Own Shares
13th Jul 20207:00 amRNSSHARE BUY-BACK PROGRAMME
9th Jul 20205:45 pmRNSDirector/PDMR Shareholding
25th Jun 20203:00 pmRNSResult of AGM
22nd Jun 20207:00 amRNSNet Asset Value(s) and Monthly Factsheet
22nd Jun 20207:00 amRNSActivation of Discount Control Mechanism
19th Jun 20204:30 pmRNSChange of AGM Venue
29th May 20205:30 pmRNSNotice of AGM
28th May 20205:30 pmRNSHolding(s) in Company
26th May 20207:00 amRNSNEW CREDIT FACILITY
22nd May 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
14th May 20203:00 pmRNSDividend Declaration
7th May 20205:30 pmRNSDate of Annual General Meeting
27th Apr 202012:30 pmRNSArticles of Association
23rd Apr 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Apr 202012:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20205:40 pmRNSHolding(s) in Company
20th Mar 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Mar 20202:00 pmRNSREPLACEMENT: Annual Financial Report
10th Mar 20207:00 amRNSAnnual Financial Report
21st Feb 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Feb 20205:00 pmRNSDividend Declaration
17th Feb 202010:10 amRNSNotice of Full Year Results
7th Feb 20207:00 amRNSNEW INVESTMENT
27th Jan 20204:48 pmRNSHolding(s) in Company
22nd Jan 20204:00 pmRNSNet Asset Value(s)
20th Dec 20194:00 pmRNSNet Asset Value(s)
18th Dec 201912:15 pmRNSNew Investment
13th Dec 20192:01 pmRNSCorrection: New Investment
13th Dec 20191:35 pmRNSNew Investment
12th Dec 20192:15 pmRNSHolding(s) in Company
21st Nov 20194:00 pmRNSNet Asset Value(s)
13th Nov 20197:00 amRNSNew Investments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.